OCC Applauds FDA for Approval of New Obesity Drug

Today, members of the Obesity Care Continuum (OCC) applauded the Food and Drug Administration’s (FDA) approval of a new obesity drug – Belviq (lorcaserin HCl). Belviq is the first obesity drug to be approved in the past 13 years.

To view the full release, click here.



Leave a Reply



© 2014 Obesity Action Coalition 4511 North Himes Avenue • Suite 250 • Tampa, Florida 33614 • (800) 717-3117